Helping to address the over treatment of prostate cancer: Tools to differentiate lethal and non-lethal phenotype in prostate cancer

Asian Journal of Andrology

Volumn 14, Issue 3, 2012, Pages 347-348

  Getzenberg, Robert H ^a   Ballentine Carter, H ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CANCER TESTIS ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

CANCER CLASSIFICATION; CLINICAL ASSESSMENT TOOL; DIETARY INTAKE; EDITORIAL; HUMAN; LIFESTYLE MODIFICATION; PHENOTYPE; PROSTATE CANCER; QUALITY OF LIFE; RISK ASSESSMENT; TREATMENT PLANNING;

DELIVERY OF HEALTH CARE; DISEASE PROGRESSION; HUMANS; MALE; MASS SCREENING; PROSTATIC NEOPLASMS; RISK ASSESSMENT; UNNECESSARY PROCEDURES;

EID: 84860846595     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2012.34     Document Type: Editorial

References (0)